Metabolite profiling measures small molecules across biological systems, revealing biochemical activity, pathway changes, disease mechanisms, treatment response, and metabolic signatures of health and disease.
Metabolite profiling is a foundational approach in metabolomics. It measures small molecules such as amino acids, organic acids, sugars, nucleotides, and other biochemical intermediates that reflect active cellular metabolism and physiological state.
At PanorOmics, metabolite profiling is presented as a core metabolomics research area: the starting point for metabolic phenotyping, pathway interpretation, disease biomarker discovery, exposure analysis, and multi-omics systems biology.
Broadly measuring metabolites across biological samples to discover biochemical patterns, disease signatures, and pathway alterations.
Measuring selected metabolites or metabolite classes with focused, quantitative analytical methods.
Identifying and interpreting detected metabolites using spectral databases, chemical standards, and computational tools.
Comparing metabolite profiles across tissues, treatments, disease states, time points, or biological conditions.
Liquid chromatography mass spectrometry used for sensitive detection of diverse metabolites across complex biological samples.
Gas chromatography mass spectrometry used for volatile, derivatized, and small-molecule metabolite profiling.
Reproducible, non-destructive metabolite measurement technology used for metabolite profiling and metabolic studies.
Analytical approach useful for charged and polar metabolites, including amino acids, organic acids, and energy metabolites.
Computational approaches that support metabolite identification, spectral interpretation, and pattern discovery.
Captures broad metabolite patterns to characterize biochemical activity across biological systems.
Measures predefined metabolite groups such as amino acids, organic acids, nucleotides, or energy metabolites.
Blood-based metabolite profiling used to study circulating biochemical signatures.
Non-invasive profiling used for metabolic monitoring, exposure assessment, and disease biomarker discovery.
Measures metabolites directly within tissues to study local biochemical activity and disease mechanisms.
Tracks metabolite changes over time during development, treatment, stress, disease progression, or recovery.
Related metabolomic approaches such as metabolic phenotyping, pathway analysis, and disease biomarker discovery are explored across the Metabolomics Research Center.
Routine biochemical testing established metabolites as measurable indicators of physiology, nutrition, disease, and organ function.
Analytical chemistry and clinical biochemistry expanded metabolite measurement across biological fluids and disease states.
High-throughput analytical platforms shifted metabolite research from individual compounds toward system-wide profiling.
Metabolomics became a major omics field connecting metabolite profiles with genotype, phenotype, environment, and disease biology.
LC-MS, GC-MS, and related technologies enabled sensitive, large-scale metabolite detection and comparative profiling.
Metabolite profiling increasingly integrates pathway analysis, disease phenotyping, biomarker discovery, and multi-omics interpretation.
AI increasingly supports metabolite annotation, pattern recognition, pathway interpretation, and metabolic signature discovery.
Continue exploring the Metabolomics Research Center.
Continue exploring the Metabolomics Research Center.
Continue exploring the Metabolomics Research Center.